Global Clinical Communications(TM) Hires Marshall Graves as Vice President of Clinical Solutions

Saturday, May 22, 2010 General News J E 4

NASHVILLE, Tenn., May 21 Global Clinical Communications (GCC) has hired Marshall Graves as vice president of clinical solutions.

GCC, a leading supplier of validated clinical research technology solutions and services for site activation and management, announces that Graves will lead the clinical solutions division, including the rapidly growing and popular Compass(TM) virtual workspace portal site activation and management software.

Graves comes to GCC with a reputation as an expert in technology-based clinical research solutions, after many years of senior management in companies providing solutions for pharmaceutical clinical research. He served as CEO of Virtual Clinical Solutions, where he was largely credited with a successful turnaround of that company.

"Clinical research continues to benefit from advances in technology. With the addition of Marshall Graves, combined with GCC's cutting-edge technologies, the industry is poised for improved efficiencies and reduced costs -- all leading to better clinical outcomes," says Bill Nelson, CEO of GCC.

"I'm thrilled to be part of such a dynamic company," says Graves. "GCC has an incredible team of talented professionals and an amazing track record of pioneering technology-based clinical research solutions that greatly advance good clinical practices. The pipeline of exciting new technologies is unrivaled."

For more information, contact Global Clinical Communications at (615) 250-7064 or email contact@globalclinicalcommunications, or visit the website at

2963 Foster Creighton

Nashville, TN, 37204

SOURCE Global Clinical Communications


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Abviva Details Patent Information for its Breast C...
LightLab Imaging Returns to EuroPCR 2010 With Stro...